Back to Screener

Healthcare

SAB Biotherapeutics, Inc.(SABS)

Live Price

Offline

$4.00

+3.63% today

1Y Change

+88.07%

Window

Jun 23, 2025 โ†’ Jun 10, 2026

Market Cap
$40.00M
Revenue Growth
-100.0%
EPS Growth
+106.0%
Dividend Yield
0.0%

Coverage: 243 bars ยท Jun 23, 2025 โ†’ Jun 10, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

SAB Biotherapeutics, Inc. (SABS) is a Healthcare stock with a market cap of $40.00M and listed on NASDAQ. The stock last traded around $4.00 and up 88.1% across the available one-year price window (Jun 23, 2025 โ†’ Jun 10, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of +106.0%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS +106.0%, free cash flow -32.0% with operating margin 0.0% and ROIC -30.0%. Valuation is more restrained than many high-expectation growth names at P/E 5.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SABS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

SABS

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

SABS Max Drawdown

-33.80%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for SABS and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 8, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 8, 26
โ€”
Est -0.21
โ€”
โ€”
Est 125.0B
โ€”
May 8
โ€”
Mar 9, 26
โœ—
-0.46
Est -0.16
-187.5%
โ€”
Est 100.0B
โ€”
Mar 9
โ€”
Nov 14, 25
โœ“
-0.21
Est -0.59
+64.4%
โ€”
Est 100.0B
โ€”
Nov 14
โ€”
Aug 7, 25
โœ—
-1.09
Est -0.82
-32.9%
โ€”
Est 83.3B
โ€”
Aug 7
โ€”
May 9, 25
โœ“
-0.56
Est -1.00
+44.0%
โ€”
Est 125.0B
โ€”
May 9
โ€”
Mar 28, 25
โœ—
-1.23
Est -1.16
-6.0%
100.0B
Est 120.0B
-16.7%
Mar 28
โ€”
Nov 6, 24
โœ—
-1.12
Est -1.07
-4.7%
-410M
Est 150.0B
-100.3%
Nov 6
โ€”
Aug 8, 24
โœ“
-0.79
Est -1.13
+30.1%
263.1B
Est โ€”
โ€”
Aug 8
โ€”
May 20, 24
โœ“
-0.54
Est -0.98
+44.9%
944.6B
Est โ€”
โ€”
May 20
โ€”
Apr 1, 24
โœ—
-3.38
Est -0.62
-445.2%
305.0B
Est โ€”
โ€”
Apr 1
โ€”
Nov 13, 23
โ€”
-1.00
Est -1.00
0.0%
1267.0B
Est 12.0B
+10488.3%
Nov 13
โ€”
Aug 21, 23
โœ“
-1.40
Est -1.60
+12.5%
85.5B
Est 410.0B
-79.1%
Aug 21
โ€”
May 16, 23
โœ—
-1.50
Est -0.80
-87.5%
600.0B
Est 2540.0B
-76.4%
May 16
โ€”
Apr 14, 23
โœ—
-1.56
Est -0.04
-3807.0%
2161.0B
Est 6500.0B
-66.8%
Apr 14
โ€”
Nov 15, 22
โœ—
-1.60
Est -1.40
-14.3%
3590.0B
Est 5902.9B
-39.2%
Nov 15
โ€”
Aug 10, 22
โœ“
-1.10
Est -1.30
+15.4%
6351.0B
Est 10800.0B
-41.2%
Aug 10
โ€”
May 12, 22
โœ—
-1.50
Est -1.20
-25.0%
11803.0B
Est 11466.7B
+2.9%
May 12
โ€”
Mar 29, 22
โœ—
-0.66
Est -0.11
-500.0%
60876.0B
Est 60876.0B
0.0%
Mar 29
โ€”
Nov 22, 21
โœ“
-0.02
Est -0.09
+77.8%
14700.0B
Est 16896.7B
-13.0%
Nov 22
โ€”
Aug 9, 21
-0.68
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Aug 9
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener